Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach
Aims The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic se...
Gespeichert in:
Veröffentlicht in: | The Journal of thoracic and cardiovascular surgery 2009-12, Vol.138 (6), p.1339-1348 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1348 |
---|---|
container_issue | 6 |
container_start_page | 1339 |
container_title | The Journal of thoracic and cardiovascular surgery |
container_volume | 138 |
creator | Montant, Patrick, MD Chenot, Fabien, MD Robert, Annie, PhD Vancraeynest, David, MD Pasquet, Agnès, MD, PhD Gerber, Bernard, MD, PhD Noirhomme, Philippe, MD El Khoury, Gébrine, MD Vanoverschelde, Jean-Louis, MD, PhD |
description | Aims The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair. Methods One hundred ninety-two asymptomatic patients (mean age, 63 ± 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years. Results Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a “conservative approach” group (n = 67) and an “early surgery” group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% ± 7% vs 86% ± 4%, log-rank < 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively. Conclusion Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy. |
doi_str_mv | 10.1016/j.jtcvs.2009.03.046 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734154953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0022522309005017</els_id><sourcerecordid>734154953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-980b605678c294802db951e6f8336c1c4ca45513f35052fa5c55c225fa455b7a3</originalsourceid><addsrcrecordid>eNqFks-q1DAUxoso3uvVJxAkG9HNjCdJ02kFhcvFfzDgQgV3IZOedjK2ac3JdJid7-BT-Ro-iakzKLhxk0Dy-77vkC9Z9pDDkgMvnu2Wu2gnWgqAaglyCXlxK7vkUK0WRak-384uAYRYKCHkRXaPaAcAK-DV3eyCV0UBslSX2Y_14NtFxNAz2ofJTaZjzjNDx36MQ2-is2xMK_pI7ODilhFOGJDV2KLHkK4mZL2LIQkDtvvQupgOB_-cXbMxDCN6cvHIyA4Bf377vjGENbNDP5rgaPBsg_GAmCI9QxO64zxH62yyo2QasT2mq5qZpPGEYTolxoAm9mkqZsaUYuz2fnanMR3hg_N-lX16_erjzdvF-v2bdzfX64VVgsdFVcKmAFWsSiuqvARRbyrFsWhKKQvLbW5NrhSXjVSgRGOUVcoKoZr5eLMy8ip7cvJNsV_3SFH3jix2nfE47EmvZM5VXimZSHkibRiIAjZ6DK434ag56LlCvdO_K9RzhRqkThUm1aOz_37TY_1Xc-4sAY_PgKH0TE0w3jr6wwnBy7ysysQ9PXFb124PLqCm3nRdsuVzLHFZ6kJzKauEvjihmB5uchg02VS5xTrJbNT14P4z88t_9LZzfi7xCx6RdsM--NSJ5pqEBv1h_pjzv4QKQAFfyV8y0eTP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734154953</pqid></control><display><type>article</type><title>Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Montant, Patrick, MD ; Chenot, Fabien, MD ; Robert, Annie, PhD ; Vancraeynest, David, MD ; Pasquet, Agnès, MD, PhD ; Gerber, Bernard, MD, PhD ; Noirhomme, Philippe, MD ; El Khoury, Gébrine, MD ; Vanoverschelde, Jean-Louis, MD, PhD</creator><creatorcontrib>Montant, Patrick, MD ; Chenot, Fabien, MD ; Robert, Annie, PhD ; Vancraeynest, David, MD ; Pasquet, Agnès, MD, PhD ; Gerber, Bernard, MD, PhD ; Noirhomme, Philippe, MD ; El Khoury, Gébrine, MD ; Vanoverschelde, Jean-Louis, MD, PhD</creatorcontrib><description>Aims The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair. Methods One hundred ninety-two asymptomatic patients (mean age, 63 ± 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years. Results Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a “conservative approach” group (n = 67) and an “early surgery” group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% ± 7% vs 86% ± 4%, log-rank < 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively. Conclusion Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy.</description><identifier>ISSN: 0022-5223</identifier><identifier>EISSN: 1097-685X</identifier><identifier>DOI: 10.1016/j.jtcvs.2009.03.046</identifier><identifier>PMID: 19660385</identifier><identifier>CODEN: JTCSAQ</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Atrial Fibrillation - complications ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiothoracic Surgery ; Echocardiography ; Endocardial and cardiac valvular diseases ; Female ; Heart ; Humans ; Hypertension, Pulmonary - complications ; Male ; Medical sciences ; Middle Aged ; Mitral Valve Insufficiency - complications ; Mitral Valve Insufficiency - mortality ; Mitral Valve Insufficiency - surgery ; Mitral Valve Insufficiency - therapy ; Pneumology ; Propensity Score ; Proportional Hazards Models ; Treatment Outcome</subject><ispartof>The Journal of thoracic and cardiovascular surgery, 2009-12, Vol.138 (6), p.1339-1348</ispartof><rights>The American Association for Thoracic Surgery</rights><rights>2009 The American Association for Thoracic Surgery</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-980b605678c294802db951e6f8336c1c4ca45513f35052fa5c55c225fa455b7a3</citedby><cites>FETCH-LOGICAL-c521t-980b605678c294802db951e6f8336c1c4ca45513f35052fa5c55c225fa455b7a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022522309005017$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22184898$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19660385$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Montant, Patrick, MD</creatorcontrib><creatorcontrib>Chenot, Fabien, MD</creatorcontrib><creatorcontrib>Robert, Annie, PhD</creatorcontrib><creatorcontrib>Vancraeynest, David, MD</creatorcontrib><creatorcontrib>Pasquet, Agnès, MD, PhD</creatorcontrib><creatorcontrib>Gerber, Bernard, MD, PhD</creatorcontrib><creatorcontrib>Noirhomme, Philippe, MD</creatorcontrib><creatorcontrib>El Khoury, Gébrine, MD</creatorcontrib><creatorcontrib>Vanoverschelde, Jean-Louis, MD, PhD</creatorcontrib><title>Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach</title><title>The Journal of thoracic and cardiovascular surgery</title><addtitle>J Thorac Cardiovasc Surg</addtitle><description>Aims The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair. Methods One hundred ninety-two asymptomatic patients (mean age, 63 ± 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years. Results Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a “conservative approach” group (n = 67) and an “early surgery” group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% ± 7% vs 86% ± 4%, log-rank < 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively. Conclusion Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Atrial Fibrillation - complications</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiothoracic Surgery</subject><subject>Echocardiography</subject><subject>Endocardial and cardiac valvular diseases</subject><subject>Female</subject><subject>Heart</subject><subject>Humans</subject><subject>Hypertension, Pulmonary - complications</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mitral Valve Insufficiency - complications</subject><subject>Mitral Valve Insufficiency - mortality</subject><subject>Mitral Valve Insufficiency - surgery</subject><subject>Mitral Valve Insufficiency - therapy</subject><subject>Pneumology</subject><subject>Propensity Score</subject><subject>Proportional Hazards Models</subject><subject>Treatment Outcome</subject><issn>0022-5223</issn><issn>1097-685X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks-q1DAUxoso3uvVJxAkG9HNjCdJ02kFhcvFfzDgQgV3IZOedjK2ac3JdJid7-BT-Ro-iakzKLhxk0Dy-77vkC9Z9pDDkgMvnu2Wu2gnWgqAaglyCXlxK7vkUK0WRak-384uAYRYKCHkRXaPaAcAK-DV3eyCV0UBslSX2Y_14NtFxNAz2ofJTaZjzjNDx36MQ2-is2xMK_pI7ODilhFOGJDV2KLHkK4mZL2LIQkDtvvQupgOB_-cXbMxDCN6cvHIyA4Bf377vjGENbNDP5rgaPBsg_GAmCI9QxO64zxH62yyo2QasT2mq5qZpPGEYTolxoAm9mkqZsaUYuz2fnanMR3hg_N-lX16_erjzdvF-v2bdzfX64VVgsdFVcKmAFWsSiuqvARRbyrFsWhKKQvLbW5NrhSXjVSgRGOUVcoKoZr5eLMy8ip7cvJNsV_3SFH3jix2nfE47EmvZM5VXimZSHkibRiIAjZ6DK434ag56LlCvdO_K9RzhRqkThUm1aOz_37TY_1Xc-4sAY_PgKH0TE0w3jr6wwnBy7ysysQ9PXFb124PLqCm3nRdsuVzLHFZ6kJzKauEvjihmB5uchg02VS5xTrJbNT14P4z88t_9LZzfi7xCx6RdsM--NSJ5pqEBv1h_pjzv4QKQAFfyV8y0eTP</recordid><startdate>20091201</startdate><enddate>20091201</enddate><creator>Montant, Patrick, MD</creator><creator>Chenot, Fabien, MD</creator><creator>Robert, Annie, PhD</creator><creator>Vancraeynest, David, MD</creator><creator>Pasquet, Agnès, MD, PhD</creator><creator>Gerber, Bernard, MD, PhD</creator><creator>Noirhomme, Philippe, MD</creator><creator>El Khoury, Gébrine, MD</creator><creator>Vanoverschelde, Jean-Louis, MD, PhD</creator><general>Mosby, Inc</general><general>AATS/WTSA</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20091201</creationdate><title>Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach</title><author>Montant, Patrick, MD ; Chenot, Fabien, MD ; Robert, Annie, PhD ; Vancraeynest, David, MD ; Pasquet, Agnès, MD, PhD ; Gerber, Bernard, MD, PhD ; Noirhomme, Philippe, MD ; El Khoury, Gébrine, MD ; Vanoverschelde, Jean-Louis, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-980b605678c294802db951e6f8336c1c4ca45513f35052fa5c55c225fa455b7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Atrial Fibrillation - complications</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiothoracic Surgery</topic><topic>Echocardiography</topic><topic>Endocardial and cardiac valvular diseases</topic><topic>Female</topic><topic>Heart</topic><topic>Humans</topic><topic>Hypertension, Pulmonary - complications</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mitral Valve Insufficiency - complications</topic><topic>Mitral Valve Insufficiency - mortality</topic><topic>Mitral Valve Insufficiency - surgery</topic><topic>Mitral Valve Insufficiency - therapy</topic><topic>Pneumology</topic><topic>Propensity Score</topic><topic>Proportional Hazards Models</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montant, Patrick, MD</creatorcontrib><creatorcontrib>Chenot, Fabien, MD</creatorcontrib><creatorcontrib>Robert, Annie, PhD</creatorcontrib><creatorcontrib>Vancraeynest, David, MD</creatorcontrib><creatorcontrib>Pasquet, Agnès, MD, PhD</creatorcontrib><creatorcontrib>Gerber, Bernard, MD, PhD</creatorcontrib><creatorcontrib>Noirhomme, Philippe, MD</creatorcontrib><creatorcontrib>El Khoury, Gébrine, MD</creatorcontrib><creatorcontrib>Vanoverschelde, Jean-Louis, MD, PhD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montant, Patrick, MD</au><au>Chenot, Fabien, MD</au><au>Robert, Annie, PhD</au><au>Vancraeynest, David, MD</au><au>Pasquet, Agnès, MD, PhD</au><au>Gerber, Bernard, MD, PhD</au><au>Noirhomme, Philippe, MD</au><au>El Khoury, Gébrine, MD</au><au>Vanoverschelde, Jean-Louis, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach</atitle><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle><addtitle>J Thorac Cardiovasc Surg</addtitle><date>2009-12-01</date><risdate>2009</risdate><volume>138</volume><issue>6</issue><spage>1339</spage><epage>1348</epage><pages>1339-1348</pages><issn>0022-5223</issn><eissn>1097-685X</eissn><coden>JTCSAQ</coden><abstract>Aims The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair. Methods One hundred ninety-two asymptomatic patients (mean age, 63 ± 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years. Results Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a “conservative approach” group (n = 67) and an “early surgery” group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% ± 7% vs 86% ± 4%, log-rank < 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively. Conclusion Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>19660385</pmid><doi>10.1016/j.jtcvs.2009.03.046</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-5223 |
ispartof | The Journal of thoracic and cardiovascular surgery, 2009-12, Vol.138 (6), p.1339-1348 |
issn | 0022-5223 1097-685X |
language | eng |
recordid | cdi_proquest_miscellaneous_734154953 |
source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Atrial Fibrillation - complications Biological and medical sciences Cardiology. Vascular system Cardiothoracic Surgery Echocardiography Endocardial and cardiac valvular diseases Female Heart Humans Hypertension, Pulmonary - complications Male Medical sciences Middle Aged Mitral Valve Insufficiency - complications Mitral Valve Insufficiency - mortality Mitral Valve Insufficiency - surgery Mitral Valve Insufficiency - therapy Pneumology Propensity Score Proportional Hazards Models Treatment Outcome |
title | Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T19%3A24%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20survival%20in%20asymptomatic%20patients%20with%20severe%20degenerative%20mitral%20regurgitation:%20A%20propensity%20score%E2%80%93based%20comparison%20between%20an%20early%20surgical%20strategy%20and%20a%20conservative%20treatment%20approach&rft.jtitle=The%20Journal%20of%20thoracic%20and%20cardiovascular%20surgery&rft.au=Montant,%20Patrick,%20MD&rft.date=2009-12-01&rft.volume=138&rft.issue=6&rft.spage=1339&rft.epage=1348&rft.pages=1339-1348&rft.issn=0022-5223&rft.eissn=1097-685X&rft.coden=JTCSAQ&rft_id=info:doi/10.1016/j.jtcvs.2009.03.046&rft_dat=%3Cproquest_cross%3E734154953%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734154953&rft_id=info:pmid/19660385&rft_els_id=1_s2_0_S0022522309005017&rfr_iscdi=true |